Kilter Group’s Bausch Health BHC Stock Holding History

Kilter Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37	Closed	-$239	–	1413
2025 Q3	$239	Hold	37	–	–	﹤0.01%	1154
2025 Q2	$247	Buy	+37	New	+$190	﹤0.01%	1084

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kilter Group's BHC Position: Q4 2025 in Review

Kilter Group sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 37 shares — an estimated $239 sold.

Kilter Group first reported a position in BHC in Q2 2025 and held it in 2 quarters. The position peaked at $247 in Q2 2025. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

Kilter Group reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
Kilter Group sold 37 Bausch Health shares in Q4 2025, an estimated $239.
Kilter Group first reported a position in Bausch Health in Q2 2025 and held it in 2 quarters.
Kilter Group's Bausch Health position peaked at $247 in Q2 2025.
236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Kilter Group's 13F filing for Q4 2025, filed 13 Feb 2026.